End-of-day quote
Xetra
04:30:00 05/02/2024 am IST
|
5-day change
|
1st Jan Change
|
32.55
EUR
|
-1.51%
|
|
-1.66%
|
+0.31%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,846
|
5,858
|
4,921
|
4,183
|
4,897
|
5,120
|
-
|
-
|
Enterprise Value (EV)
1 |
5,639
|
5,679
|
4,824
|
4,243
|
4,785
|
4,916
|
4,752
|
4,615
|
P/E ratio
|
26.9
x
|
29.2
x
|
21.8
x
|
17.4
x
|
19.3
x
|
19.1
x
|
16.8
x
|
15.9
x
|
Yield
|
2.2%
|
2.13%
|
2.58%
|
3.27%
|
2.75%
|
2.67%
|
2.81%
|
2.95%
|
Capitalization / Revenue
|
2.27
x
|
2.46
x
|
1.71
x
|
1.23
x
|
1.38
x
|
1.42
x
|
1.37
x
|
1.32
x
|
EV / Revenue
|
2.19
x
|
2.39
x
|
1.68
x
|
1.24
x
|
1.35
x
|
1.37
x
|
1.27
x
|
1.19
x
|
EV / EBITDA
|
14.5
x
|
14.8
x
|
10.7
x
|
9.24
x
|
9.36
x
|
9.43
x
|
8.29
x
|
7.78
x
|
EV / FCF
|
32.2
x
|
23.9
x
|
54.2
x
|
69.6
x
|
10.3
x
|
16.4
x
|
15
x
|
14.1
x
|
FCF Yield
|
3.1%
|
4.19%
|
1.85%
|
1.44%
|
9.72%
|
6.08%
|
6.69%
|
7.07%
|
Price to Book
|
3.93
x
|
4.09
x
|
3.17
x
|
2.48
x
|
3.11
x
|
3.06
x
|
2.65
x
|
2.45
x
|
Nbr of stocks (in thousands)
|
1,39,000
|
1,39,000
|
1,39,000
|
1,38,190
|
1,34,629
|
1,31,948
|
-
|
-
|
Reference price
2 |
44.16
|
46.44
|
39.92
|
32.74
|
40.30
|
43.66
|
43.66
|
43.66
|
Announcement Date
|
20/02/20
|
09/03/21
|
18/03/22
|
08/03/23
|
12/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,572
|
2,378
|
2,871
|
3,412
|
3,541
|
3,596
|
3,750
|
3,880
|
EBITDA
1 |
389
|
383
|
449
|
459
|
511
|
521.1
|
573.1
|
593.1
|
EBIT
1 |
321
|
313
|
363
|
365
|
413
|
439.4
|
487.2
|
511.2
|
Operating Margin
|
12.48%
|
13.16%
|
12.64%
|
10.7%
|
11.66%
|
12.22%
|
12.99%
|
13.17%
|
Earnings before Tax (EBT)
1 |
317
|
308
|
358
|
357
|
403
|
428.6
|
478.3
|
506.4
|
Net income
1 |
228
|
220
|
253
|
259
|
282
|
303.7
|
342.9
|
363
|
Net margin
|
8.86%
|
9.25%
|
8.81%
|
7.59%
|
7.96%
|
8.45%
|
9.14%
|
9.36%
|
EPS
2 |
1.640
|
1.590
|
1.830
|
1.880
|
2.090
|
2.288
|
2.598
|
2.747
|
Free Cash Flow
1 |
175
|
238
|
89
|
61
|
465
|
299
|
317.8
|
326.1
|
FCF margin
|
6.8%
|
10.01%
|
3.1%
|
1.79%
|
13.13%
|
8.31%
|
8.47%
|
8.41%
|
FCF Conversion (EBITDA)
|
44.99%
|
62.14%
|
19.82%
|
13.29%
|
91%
|
57.37%
|
55.45%
|
54.99%
|
FCF Conversion (Net income)
|
76.75%
|
108.18%
|
35.18%
|
23.55%
|
164.89%
|
98.44%
|
92.68%
|
89.84%
|
Dividend per Share
2 |
0.9700
|
0.9900
|
1.030
|
1.070
|
1.110
|
1.168
|
1.226
|
1.287
|
Announcement Date
|
20/02/20
|
09/03/21
|
18/03/22
|
08/03/23
|
12/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,411
|
742
|
808
|
832
|
1,640
|
902
|
870
|
936
|
946
|
1,882
|
816
|
843
|
877
|
881
|
879.5
|
831.4
|
916.6
|
908.5
|
EBITDA
1 |
-
|
107
|
-
|
-
|
-
|
124
|
109
|
-
|
-
|
-
|
-
|
125
|
131
|
135.6
|
133.6
|
115.9
|
140
|
138.9
|
EBIT
|
191
|
84
|
93
|
87
|
180
|
100
|
85
|
103
|
97
|
200
|
133
|
100
|
107
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
13.54%
|
11.32%
|
11.51%
|
10.46%
|
10.98%
|
11.09%
|
9.77%
|
11%
|
10.25%
|
10.63%
|
16.3%
|
11.86%
|
12.2%
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
99
|
106
|
115.9
|
113.9
|
95.88
|
119.9
|
119.2
|
Net income
1 |
-
|
56
|
67
|
61
|
128
|
70
|
61
|
73
|
68
|
141
|
77
|
64
|
77
|
81.06
|
79.62
|
66.99
|
83.72
|
83.19
|
Net margin
|
-
|
7.55%
|
8.29%
|
7.33%
|
7.8%
|
7.76%
|
7.01%
|
7.8%
|
7.19%
|
7.49%
|
9.44%
|
7.59%
|
8.78%
|
9.2%
|
9.05%
|
8.06%
|
9.13%
|
9.16%
|
EPS
|
0.9800
|
0.4100
|
0.4800
|
0.4500
|
0.9300
|
0.5000
|
0.4500
|
0.5400
|
0.5000
|
1.040
|
0.5800
|
0.4700
|
0.5800
|
-
|
-
|
-
|
0.6285
|
0.6245
|
Dividend per Share
2 |
-
|
1.030
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.110
|
-
|
-
|
-
|
1.155
|
-
|
-
|
Announcement Date
|
30/07/21
|
18/03/22
|
29/04/22
|
29/07/22
|
29/07/22
|
28/10/22
|
08/03/23
|
28/04/23
|
28/07/23
|
28/07/23
|
27/10/23
|
12/03/24
|
30/04/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
60
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
207
|
179
|
97
|
-
|
112
|
204
|
368
|
506
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.1307
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
175
|
238
|
89
|
61
|
465
|
299
|
318
|
326
|
ROE (net income / shareholders' equity)
|
15.1%
|
14%
|
15.2%
|
14.4%
|
15.5%
|
16.7%
|
16.4%
|
16%
|
ROA (Net income/ Total Assets)
|
11.7%
|
10.6%
|
11.4%
|
10.7%
|
11.4%
|
12.6%
|
13.5%
|
13.2%
|
Assets
1 |
1,957
|
2,072
|
2,216
|
2,417
|
2,473
|
2,413
|
2,537
|
2,744
|
Book Value Per Share
2 |
11.20
|
11.40
|
12.60
|
13.20
|
12.90
|
14.30
|
16.50
|
17.90
|
Cash Flow per Share
2 |
2.370
|
2.590
|
2.590
|
0.9200
|
4.030
|
2.380
|
2.690
|
2.720
|
Capex
1 |
154
|
122
|
80
|
69
|
83
|
72.8
|
86.5
|
95
|
Capex / Sales
|
5.99%
|
5.13%
|
2.79%
|
2.02%
|
2.34%
|
2.02%
|
2.31%
|
2.45%
|
Announcement Date
|
20/02/20
|
09/03/21
|
18/03/22
|
08/03/23
|
12/03/24
|
-
|
-
|
-
|
Last Close Price
43.66
EUR Average target price
48.7
EUR Spread / Average Target +11.54% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.28% | 102B | | -2.28% | 65.53B | | +46.19% | 41.76B | | +19.68% | 38.66B | | +4.90% | 32.28B | | +9.53% | 19.57B | | +15.64% | 16.77B | | +21.26% | 15.08B | | +11.59% | 14.83B |
Other Commodity Chemicals
|